THAP1 mutations are infrequent in spasmodic dysphonia

Mov Disord. 2011 Aug 15;26(10):1952-4. doi: 10.1002/mds.23682. Epub 2011 Apr 29.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Dyskinesia Agents / therapeutic use
  • Apoptosis Regulatory Proteins / genetics*
  • Botulinum Toxins / therapeutic use
  • Child
  • DNA-Binding Proteins / genetics*
  • Dysphonia / complications
  • Dysphonia / drug therapy
  • Dysphonia / genetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Netherlands
  • Nuclear Proteins / genetics*
  • Voice Disorders / complications
  • Voice Disorders / genetics*
  • Young Adult

Substances

  • Anti-Dyskinesia Agents
  • Apoptosis Regulatory Proteins
  • DNA-Binding Proteins
  • Nuclear Proteins
  • THAP1 protein, human
  • Botulinum Toxins